Richard B. Bartram
2019
In 2019, Richard B. Bartram earned a total compensation of $485.5K as Chief Financial Officer at Esperion Therapeutics, a 81% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $136,000 |
|---|---|
| Salary | $340,000 |
| Other | $9,500 |
| Total | $485,500 |
Bartram received $340K in salary, accounting for 70% of the total pay in 2019.
Bartram also received $136K in non-equity incentive plan and $9.5K in other compensation.
Rankings
In 2019, Richard B. Bartram's compensation ranked 11,845th out of 13,971 executives tracked by ExecPay. In other words, Bartram earned more than 15.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,845 out of 13,971 | 15th |
Division Manufacturing | 4,793 out of 5,695 | 16th |
Major group Chemicals And Allied Products | 1,890 out of 2,194 | 14th |
Industry group Drugs | 1,628 out of 1,880 | 13th |
Industry Pharmaceutical Preparations | 1,208 out of 1,392 | 13th |
Pay ratio
| Richard B. Bartram's Pay | $485,500 |
|---|---|
| Median Employee's Pay | $242,988 |
| Pay Ratio | 2to 1 |
In 2019, the annual total compensation of Richard B. Bartram was $485,500.
The annual total compensation of the median employee at Esperion Therapeutics was $242,988.
The ratio of Richard B. Bartram's pay to the pay of median employee was therefore 2 to one.
Source: SEC filing on April 16, 2020.
Bartram's colleagues
We found two more compensation records of executives who worked with Richard B. Bartram at Esperion Therapeutics in 2019.